Co-Diagnostics Cost of Goods Sold 2017-2024 | CODX
Co-Diagnostics cost of goods sold from 2017 to 2024. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
| Co-Diagnostics Annual Cost of Goods Sold (Millions of US $) |
|
|---|---|
| 2023 | $4 |
| 2022 | $5 |
| 2021 | $12 |
| 2020 | $17 |
| 2019 | $0 |
| 2018 | $0 |
| 2017 | $0 |
| 2016 | $ |
| Co-Diagnostics Quarterly Cost of Goods Sold (Millions of US $) |
|
|---|---|
| 2024-09-30 | $0 |
| 2024-06-30 | $0 |
| 2024-03-31 | $0 |
| 2023-12-31 | $3 |
| 2023-09-30 | $0 |
| 2023-06-30 | $0 |
| 2023-03-31 | $1 |
| 2022-12-31 | $1 |
| 2022-09-30 | $1 |
| 2022-06-30 | $1 |
| 2022-03-31 | $3 |
| 2021-12-31 | $2 |
| 2021-09-30 | $3 |
| 2021-06-30 | $3 |
| 2021-03-31 | $3 |
| 2020-12-31 | $4 |
| 2020-09-30 | $6 |
| 2020-06-30 | $6 |
| 2020-03-31 | $0 |
| 2019-12-31 | $0 |
| 2019-09-30 | $0 |
| 2019-06-30 | $0 |
| 2019-03-31 | $0 |
| 2018-12-31 | |
| 2018-09-30 | |
| 2018-06-30 | |
| 2018-03-31 | |
| 2017-12-31 | |
| 2017-09-30 | |
| 2017-06-30 | $0 |
| 2017-03-31 | |
| 2016-12-31 | |
| 2016-09-30 | |
| 2016-06-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.024B | $0.007B |
| Co-Diagnostics Inc. is a molecular diagnostics company. It develops, manufactures and markets a new, state-of-the-art diagnostics technology. The Company's technology is utilized for tests which are designed using the detection and/or analysis of nucleic acid molecules. It also uses proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers. Co-Diagnostics Inc. is based in UT, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $160.880B | 29.74 |
| Elevance Health (ELV) | United States | $91.772B | 12.00 |
| Cencora (COR) | United States | $49.134B | 18.48 |
| Natera (NTRA) | United States | $23.357B | 0.00 |
| DiDi Global (DIDIY) | China | $22.601B | 0.00 |
| ICON (ICLR) | Ireland | $16.423B | 14.63 |
| Revvity (RVTY) | United States | $15.350B | 25.74 |
| Avantor (AVTR) | United States | $15.164B | 22.74 |
| BioMerieux (BMXMF) | France | $14.363B | 0.00 |
| Viatris (VTRS) | United States | $13.464B | 4.15 |
| CochLear (CHEOY) | Australia | $13.043B | 0.00 |
| Solventum (SOLV) | United States | $12.794B | 0.00 |
| Doximity (DOCS) | United States | $11.033B | 64.94 |
| Medpace Holdings (MEDP) | United States | $10.852B | 30.57 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $10.405B | 0.00 |
| HealthEquity (HQY) | United States | $9.569B | 48.01 |
| Charles River Laboratories (CRL) | United States | $8.425B | 16.28 |
| Sonic Healthcare (SKHHY) | Australia | $8.349B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $6.136B | 31.28 |
| Bausch + Lomb (BLCO) | Canada | $6.114B | 28.44 |
| BrightSpring Health Services (BTSG) | United States | $4.109B | 87.41 |
| Organon (OGN) | United States | $4.007B | 4.04 |
| Sotera Health (SHC) | United States | $3.883B | 20.77 |
| Surgery Partners (SGRY) | United States | $3.240B | 36.94 |
| Concentras Parent (CON) | United States | $2.968B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.950B | 0.00 |
| PACS (PACS) | United States | $2.214B | 0.00 |
| Premier (PINC) | United States | $2.178B | 11.33 |
| Ardent Health Partners (ARDT) | United States | $2.141B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.056B | 0.00 |
| Progyny (PGNY) | United States | $1.973B | 39.95 |
| GoodRx Holdings (GDRX) | United States | $1.818B | 47.70 |
| Teladoc Health (TDOC) | United States | $1.749B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.409B | 0.00 |
| Agilon Health (AGL) | United States | $1.376B | 0.00 |
| CareDx (CDNA) | United States | $1.250B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.201B | 11.75 |
| AMN Healthcare Services Inc (AMN) | United States | $1.048B | 7.09 |
| Embecta (EMBC) | United States | $1.042B | 7.29 |
| Establishment Labs Holdings (ESTA) | $0.897B | 0.00 | |
| Auna S.A (AUNA) | Luxembourg | $0.639B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.515B | 0.00 |
| SBC Medicals (SBC) | United States | $0.505B | 0.00 |
| DocGo (DCGO) | United States | $0.499B | 18.81 |
| Sonida Senior Living (SNDA) | United States | $0.440B | 0.00 |
| Enhabit (EHAB) | United States | $0.422B | 36.52 |
| QDM (QDMI) | Hong Kong, SAR China | $0.412B | 0.00 |
| MultiPlan (MPLN) | United States | $0.295B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.295B | 0.00 |
| Nutex Health (NUTX) | United States | $0.259B | 0.00 |
| LifeMD (LFMD) | United States | $0.241B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.219B | 0.00 |
| Beauty Health (SKIN) | United States | $0.207B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.185B | 0.00 |
| Biodesix (BDSX) | United States | $0.150B | 0.00 |
| So-Young (SY) | China | $0.108B | 18.32 |
| Oncology Institute (TOI) | United States | $0.076B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.073B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.069B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 1.60 |
| ModivCare (MODV) | United States | $0.057B | 3.10 |
| Singular Genomics Systems (OMIC) | United States | $0.050B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.035B | 0.00 |
| OncoCyte (OCX) | United States | $0.035B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.020B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.010B | 0.00 |
| KindlyMD (KDLY) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.000B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |